S446 Results from KRYPTOS, a Phase 2/3 Study of Lirentelimab (AK002) in Adults and Adolescents With EoE. (October 2022) - Chehade, Mirna; Genta, Robert M.; Leiman, David A.; Peterson, Kathryn A.; Spergel, Jonathan; Wechsler, Joshua; Bortey, Enoch; Chang, Alan T.; Hirano, Ikuo